Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's only 3x off the 52w low. That's nothing. They're supposedly going to seek a financial advisor to access a fair value on the overall merger between $35 mill - $350mill with a float of 41mill so 3x from .006 300% is nothing.. and shares are to held tight
So in other words a 45x from current price is much upside. ;) to .80 cents
This delay is due to BF Borgers.. this merger is solid and CEO and the rest that filed their form 4 are locked in even though they had gotten rid of BF in 2023 much earlier but new CPA agreed to redo their mess.. I like the transparency of this merger
I've shared some due diligence with stocktwits rwod* leas* holders regardless this company making moves under the radar .. some may decide to further look into it .. some may ignore it.. some go with the crowd. There's a saying .. early bird get the first worm
Look at the watchers
Watchers
464
52-Wk Low
$0.0054
52-Wk High
$0.0558
Right here 0.11 ..so much upside and flexibility upwards
"Common Stock Investment: The Company will secure $5,500,000 in direct investment from Alchemy Prime Holdings Shareholder for Common Stock valued at $0.11 per share, totaling 50 million shares, a significant premium to the current market price."
https://www.globenewswire.com/en/news-release/2023/12/07/2792916/0/en/FDCTech-Provides-Updates-on-the-Definitive-Agreement-for-the-Acquisition-of-Alchemy-Group-Companies-and-Direct-Investment.html
If they believe this is worth much more than $35 watch out
"FDCT may obtain an opinion from a qualified financial adviser as to the fairness of the Merger and related transactions from a financial point of view;"
I was wow out of words with this information below but when I found it in the fillings with more clarity.. this is rare gem
This from filling: keywords fairness from a qualified financial advisor WOW
"FDCT and Alchemy to be valued at $35 million and $350 million, or in its discretion, FDCT may obtain an opinion from a qualified financial adviser as to the fairness of the Merger and related transactions from a financial point of view;"
"As per the agreement, FDCT and Alchemy are to be valued at $35 million and $350 million, respectively. "
"Technically, it's a reverse merger, and under the terms, FRCTech will issue 1,700,000 shares of its Series B Preferred stocks for the acquisition. As per the agreement, FDCT and Alchemy are to be valued at $35 million and $350 million, respectively. However, due to illiquidity of FDCT securities on the OTC Markets exchange, the company is not using its market price to determine the value of this transaction."
Thanks for your input
Certainly lot of flexibility getting in early... For those who saw these shared info on stocktwits your welcome!
Hey.. you know much about this merger.. I'm back in trying absorb all the new info ..so based on fillings on merger what pps you looking for before up listing to Nasd? Be real ! CEO 30mill float 41mill
This here too sweeeeet .. what's fairness???
"FDCT and Alchemy to be valued at $35 million and $350 million, or in its discretion, FDCT may obtain an opinion from a qualified financial adviser as to the fairness of the Merger and related transactions from a financial point of view;
f. FDCT obtaining at least a $21 million debt facility directly qualified financial institution for the combined entity, which has a proforma $30,000,000 cash on hand, over $12,000,000 EBIT, and three-year CAGR of 100% and
https://www.sec.gov/Archives/edgar/data/1722731/000149315223034845/ex10-1.htm
I'm not surprised that there's little talk about this merger ... This company always was under the radar.. they're slowly accumulating small/midsize acquisition and slowly building revenues with such a low float and CEO having a huge amount of shares over 30mill of them aabb* that had over 1bill outstanding shares and got $52 mill for their gold reserves if I'm not mistaken and ran from .015- .60 cents in January of 2021 not many folks knew about it. But we have here a 41mill float valuation between $35mill - $350mill WOW sitting at.018 laughable 6 Mill market cap octqb .. only a metal detector can find these.. with solid fillings this acting like it's ready for the BIG BOARDS
NT 10Q they're on top of things .
*Rwod share outstanding updated 170,420.01
https://www.cnbc.com/quotes/RWOD
"As of May 8, 2024, RWOD has received requests to redeem a total of 1,589,776 RWOD Shares. As of May 8, 2024, the pro rata portion of the Trust Account each public share would be entitled to receive upon redemption (the “Redemption Price”) is approximately $11.20 per share (prior to the deduction of any applicable taxes). Stockholders who wish to withdraw their previously submitted redemption requests may do so by requesting RWOD’s transfer agent, Continental Stock Transfer & Trust Company, to return such shares. Based on the redemption requests received as of the date hereof, RWOD will have a total of 170,418 RWOD Shares outstanding following redemptions."
It was good that they rid themselves of BF Borgers SEC shut them down recently
We wait on Fortune CPA, Inc to deliver ;)
"On July 2, 2021, the Company appointed BF Borgers CPA PC (“BFB”) as the Company’s new independent registered public accounting firm, effective immediately, to perform independent audit services for the fiscal year ending December 31, 2021. "
"On April 18, 2023, the board of directors of FDCTech, Inc.(the "Company") terminated its relationship with its independent registered public accounting firm, BF Borgers CPA PC, Lakewood, Colorado ("BF Borgers"), effective as of April 18, 2023."
"On March 4, 2024, the Company, based on the decision of its board of directors, approved the engagement of Fortune CPA Inc., Orange, California ("Fortune") to serve as the Company's independent registered public accounting firm, commencing March 4, 2024."
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ? NO ?
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
On November 30, 2023, the registrant acquired the remaining 49.90% equity interest in Alchemy Markets Ltd. (AML, formerly NSFX Ltd), a European margin trading broker/dealer company licensed by the Malta Financial Authority. As a result, the registrant now owns one hundred percent (100.00%) interest in AML.
On November 30, 2023, the registrant acquired the remaining 100.00% equity interest in Alchemy Prime Ltd. (APL), an investment firm regulated by the Financial Conduct Authority (‘FCA’). It provides investment advice, acts as agent and principal, safeguards and administers assets in forex, equity, commodities, spread bets, and other financial assets, and provides investment advice.
The registrant is consolidating both AML's and APL’s financial statements with its financial statements and requires extra time to complete the consolidation without unreasonable time and expense.
The acquisition of NSFX Ltd. will materially increase the net assets and revenues of the registrant.
The fillings says it all.. awaiting financial
"As a result, the registrant now owns one hundred percent (100.00%) interest in AML." WOW
What a fascinating turn of events for FdcTech, Inc been known them since 2021 BIG MERGER
"As a result, the registrant now owns one hundred percent (100.00%) interest in AML." *Clapping* poison pill CEO locked up with a whooping 30mill shares.. what not to like about this reverse merger :)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ? NO ?
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
On November 30, 2023, the registrant acquired the remaining 49.90% equity interest in Alchemy Markets Ltd. (AML, formerly NSFX Ltd), a European margin trading broker/dealer company licensed by the Malta Financial Authority. As a result, the registrant now owns one hundred percent (100.00%) interest in AML.
On November 30, 2023, the registrant acquired the remaining 100.00% equity interest in Alchemy Prime Ltd. (APL), an investment firm regulated by the Financial Conduct Authority (‘FCA’). It provides investment advice, acts as agent and principal, safeguards and administers assets in forex, equity, commodities, spread bets, and other financial assets, and provides investment advice.
The registrant is consolidating both AML's and APL’s financial statements with its financial statements and requires extra time to complete the consolidation without unreasonable time and expense.
The acquisition of NSFX Ltd. will materially increase the net assets and revenues of the registrant.
Yes, $35-$350 mill on 41mill float with CEO stacked at 30 mill shares is extremely rare or rarely found in OTC land. You have to have a metal detector to locate these gems ..
They certainly improved over 3 years this low price and market cap doesn't justified their assetsnmerger
Extremely undervalued here it once was trading in the upper .80 cents back in February of 2021 never had a RS always was a low floater [img][/img]
Well, they better watch out- fillings overdue and news low float .. the combination of ingredients should already have this above .25 cents n way more.. the float is a sweet spot and value
Indeed. I knew about this back in 2021 when they had acquired condor Fx pro made my first twitter post on Nov 2021.. patience and timing.. BIG MERGER with Alchemy Group value between $35 -$350 million and CEO owns 30 mill shares .. why are wenat .014-.018?????? Wow Gem under a Rock.. due for news fillings showing merger details
This certainly very much under the radar and extremely undervalued merger.. Nasdaq bond .. awaiting 10Q n 10K CEO owns well over 30mill shares estimated of well over $500k with a float of 42mill ...
"Technically, it's a reverse merger, and under the terms, FRCTech will issue 1,700,000 shares of its Series B Preferred stocks for the acquisition. As per the agreement, FDCT and Alchemy are to be valued at $35 million and $350 million, respectively. However, due to illiquidity of FDCT securities on the OTC Markets exchange, the company is not using its market price to determine the value of this transaction."
DD sources:
https://www.financemagnates.com/institutional-forex/exclusive-fdctech-agrees-to-acquire-alchemy-group/
https://www.gurufocus.com/insider/176841/mitchell-m.-eaglstein
https://www.otcmarkets.com/stock/FDCT/security
All in the s4 pretaining to reverse split the last updated s4 on February 13, 2024 lead to Shareholders voted on April 12, 2024
News incoming that's the only reasons for this mindless talk about reverse split.
FoLKS LOCKED OUT OF This Merger .. $WENA NEXT
"NO LONGER BE Necessary "
Keywords
"Contemplated" January 4, 2022
"not been declared effective" September 30, 2023
"a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. " February 13, 2024
"The Company’s pending name change to ANEW MEDICAL Inc. and on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock."
"On November 1, 2021, the shareholders of the Company approved a name change to ANEW Medical, Inc. and approved a 1-for-2500 reverse split.
On January 4, 2022, the Company filed an Articles of Amendment with the State of Wyoming, changing its name to “ANEW Medical, Inc.” and the contemplated 1-for-2,500 reverse split. During January 2022 and in accordance with SEC Rule 10b-17 and FINRA Rule 6490, the Company submitted documents and other information to FINRA in furtherance of pursuing and obtaining approval of the subject reverse stock split and name change. The Company must submit the additional documents requested by, and necessary to obtain approval of, FINRA in connection with the subject reverse stock split and name change. As of September 30, 2023, the reverse split and name change have not been declared effective by FINRA to broker deals in the quotation system."
Merger 5/3/24 news
In 2020 COVID I was the board member who created this board. GO TIME!
Price Target $260.00
"As of April 30, 2024, MarketWatch reported that Sunshine Biopharma (SBFM) has an average recommendation of "buy" with an average target price of $15.00. The consensus rating for SBFM stock is "buy" based on the current one buy rating for SBFM. The average twelve-month price prediction for Sunshine Biopharma is $260.00 with a high price target of $260.00 and a low price target of $260.00. "
https://www.marketbeat.com/stocks/NASDAQ/SBFM/price-target/#:~:text=According%20to%20the%20issued%20ratings%20of%201,and%20a%20low%20price%20target%20of%20%24260.00
May I add imo.. 10k got nothing to do with the voting results... PR/8k can be announced at anytime furthermore the 10k can drop separately at anytime. Since 1st of April it has been complete silence. If you looked at other spac a PR come after votes are approved...take djt for example or the most recent A SPAC I "NewGenIvf" voted March 4th
Pr/news March 5th
"NewGenIvf and A SPAC I Announce Shareholder Approval of Business ...
Mar 5, 2024 —
See link for yourself
https://www.spacresearch.com/symbol/ASPAU
Taking notes 👀👀
Fillings says it all
"On November 4, 2023, the Company entered into Amendment No. 1 to the Business Combination (the “Amendment”) with the other parties thereto. The Amendment extends the termination date under the Business Combination Agreement from November 4, 2023 to March 4, 2024 (the “Termination Date”); provided, further, that (i) the right to terminate the Business Combination Agreement will not be available to the Company if any Company party’s breach of any of its covenants or obligations under the Business Combination Agreement will have proximately caused the failure to consummate the transactions contemplated by the Business Combination Agreement on or before the Termination Date, and (ii) the right to terminate the Business Combination Agreement will not be available to the Company if the Company’s breach of its covenants or obligations under the Business Combination Agreement will have proximately caused the failure to consummate the transactions contemplated by the Business Combination Agreement on or before the Termination Date."
119
Another 35k paid to extend into March 4 termination deadline
All S/4 updates "no longer be necessary" lol
Who's having a hard time comprehending below?
"NOTE 11 — SUBSEQUENT EVENTS
On January 11, 2023, a shareholder repaid a $250,000 short-term loan to the Company.
On May 30, 2023, the Company entered into a Business Combination Agreement with Redwoods Acquisition Corp., a Delaware corporation (“Redwoods”), and Redwoods wholly owned subsidiary ANEW MEDICAL Sub, Inc., a Wyoming corporation (“Merger Sub”), The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of Redwoods and the Company.
The Business Combination Agreement provides, among other things, on the Closing Date, upon the terms and conditions set forth herein and in accordance with the applicable provisions of the Wyoming Business Corporations Act (the “WBCA”), Merger Sub will merge with and into the Company, with the Company as the surviving company in the Merger and, after giving effect to such merger, a wholly owned Subsidiary of Redwoods, and each Company Share will be converted into the right to receive the Merger Consideration, on the terms and subject to the conditions set forth in the Business Combination Agreement.
The Business Combination is expected to close, and the related S4 is expected to be effective, in the third calendar quarter of 2023, but in no event later than December 4, 2023, following the receipt of the required approval by the stockholders of Redwoods and the Company, approval by the Nasdaq Stock Market (“Nasdaq”) of the initial listing application of the combined company filed in connection with the Business Combination, and the fulfillment of other customary closing conditions.
The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will *no longer be necessary* as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.
The Company evaluated all events or transactions that occurred through March 23, 2023. During this period, the Company did not have any material recognizable subsequent events.
F-81
Newwwesssssss
Newsssssssss
Newsss company shows no slowing down
940 new KIOSK in 24 states that's 39 each States spread out
Supply+demand+halving in April
$BTM could've said it any better "Provide Greater Access for Users to Fund Their Bitcoin Wallet with Cash" meanwhile blackrock hoarding at 5k per day for 3 days total of 16k before halving deadline set for April 19, 2024. If you don't see the Big Picture Demand + low supply = inflatable price
"Bitcoin Depot Plans to Install Kiosks in Roughly 940 Stores Across 24 US States to Provide Greater Access for Users to Fund Their Bitcoin Wallet with Cash"
ANEW MEDICAL, INC. entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction.
May 29, 2023
ANEW MEDICAL, INC. (OTCPK:LEAS) entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. (NasdaqGM:RWOD) from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction on May 30, 2023. As per the terms of the transaction, the Company will acquire all of the outstanding equity interests of ANEW in exchange for shares of the Company's common stock, par value $0.0001 per share (the “ Common Stock ”), based on an implied ANEW equity value of $60,000,000, to be paid to ANEW stockholders at the effective time of the Merger.
In addition, certain ANEW stockholders will be issued additional shares of the Company's Common Stock (the “ Contingent Consideration Shares ”), which will be issued as follows: (i) 2,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $12.50; (ii) 2,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $15.00; and (iii) 1,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $20.00 for 10 trading days within a 20-day trading period in the first five years following the Closing. The pro forma enterprise value of the combined company is up to $94 million, which includes up to $54 of cash held in the trust account of Redwoods, which is subject to redemption by Redwoods stockholders. These values exclude up to 5 million of additional earn-out shares that would be issued to ANEW stockholders if applicable stock performance-based requirements are met.
The proposed business combination contemplates that ANEW's stockholders will roll 100% of their equity into the combined company and will be eligible to receive additional shares pursuant to an earn-out based on the combined company's future stock performance. ANEW MEDICAL shall pay Redwoods a termination fee of $500,000 and vice-versa.
"The proposed business combination contemplates that ANEW's stockholders will roll 100% of their equity into the combined company and will be eligible to receive additional shares pursuant to an earn-out based on the combined company's future stock performance."
S4 December 29, 2023 this is what the updated s4 is about "PIPE waiver"
"Q. What conditions must be satisfied to complete the Business Combination?
A. There are a number of closing conditions in the Business Combination Agreement, including the expiration or termination of the applicable waiting period under the HSR Act and the approval by the stockholders of Redwoods of the business combination proposal, the Nasdaq proposal, the charter proposal, the incentive plan proposal and the director proposal. The receipt of proceeds of a PIPE Investment is not a closing condition however and there can be no assurance that one or more PIPE Investments will occur by the Closing of the Business Combination. For a summary of the conditions that must be satisfied or waived prior to completion of the business combination, please see the section entitled “Proposal No. 1 — The Business Combination Proposal — Certain Agreements Related to the Business Combination — Business Combination Agreement.”
Q. Are there any arrangements to help ensure that Redwoods will have sufficient funds, together with the proceeds in its trust account and from the PIPE Investment, to fund the aggregate purchase price?
A. The Business Combination Agreement provides that, prior to the Closing, ANEW shall enter into definitive agreements on terms and conditions satisfactory to Redwoods (the “PIPE Subscription Agreements”) with certain investors (the “PIPE Investors”) pursuant to which such investors, upon the terms and subject to the conditions set forth therein, will purchase shares of Redwoods Common Stock at a purchase price of ten dollars ($10.00) per share (the “PIPE Investment”); provided that the proceeds of the PIPE Investment will be equal to an aggregate of at least five million dollars ($5,000,000) immediately prior to the Closing. As of the date of this proxy statement, Redwoods and ANEW have not entered into any agreements relating to transaction financing for the proposed Merger nor have any PIPE Investors been identified. The management teams of Redwoods and ANEW are continuing to analyze the available financing options based on cost, amount made available under the financing and future effects that any financing would have on the capitalization of the Combined Company. Redwoods, Redwoods’ sponsor, ANEW and their respective directors, officers and affiliates have no prior relationships with any of the potential financing sources being considered in connection with the Merger. Redwoods will disclose the terms of any PIPE Investment and any other financing it obtains in a future amendment to this proxy statement/prospectus. Five million dollars ($5,000,000) is the minimum required cash commitment to complete the merger. For more information about the PIPE Investment, please see the section titled “Proposal No. 1 — The Business Combination Proposal — PIPE Investment.”
Please read the fillings it is helpful to do a "find in page" by utilizing your search tool within the fillings and search the fillings these wordings
Reverse split
Contemplated
Not declared effective
No longer be necessary
Waiver
Closed
Termination
These fillings are public records. You decide what benefits you
I hope this is helpful.
$LEAS "Subsequent Events "
Whoever having a hard time comprehending what this means I'm happy to help
What is occuring?
What is coming later or after?
"No longer be necessary"
SUBSEQUENT definition in American English
1. occurring or coming later or after. subsequent events. 2. following in order or succession; succeeding.
"The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.
"the Company did not have any material recognizable subsequent events."
This latest Subsequent Events dated January 3, 2024 s4
"NOTE 11 — SUBSEQUENT EVENTS
On January 11, 2023, a shareholder repaid a $250,000 short-term loan to the Company.
On May 30, 2023, the Company entered into a Business Combination Agreement with Redwoods Acquisition Corp., a Delaware corporation (“Redwoods”), and Redwoods wholly owned subsidiary ANEW MEDICAL Sub, Inc., a Wyoming corporation (“Merger Sub”), The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of Redwoods and the Company.
The Business Combination Agreement provides, among other things, on the Closing Date, upon the terms and conditions set forth herein and in accordance with the applicable provisions of the Wyoming Business Corporations Act (the “WBCA”), Merger Sub will merge with and into the Company, with the Company as the surviving company in the Merger and, after giving effect to such merger, a wholly owned Subsidiary of Redwoods, and each Company Share will be converted into the right to receive the Merger Consideration, on the terms and subject to the conditions set forth in the Business Combination Agreement.
The Business Combination is expected to close, and the related S4 is expected to be effective, in the third calendar quarter of 2023, but in no event later than December 4, 2023, following the receipt of the required approval by the stockholders of Redwoods and the Company, approval by the Nasdaq Stock Market (“Nasdaq”) of the initial listing application of the combined company filed in connection with the Business Combination, and the fulfillment of other customary closing conditions.
The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.
The Company evaluated all events or transactions that occurred through March 23, 2023. During this period, the Company did not have any material recognizable subsequent events."
Gold Reserve Act of 1934
by G Richardson · Cited by 25 — Signed by President Franklin D. Roosevelt
Blackrock stripping miners to the bones
11500 btc in two days. Halving+demand = ETF substantial gains
This time Bitcoin Reserve Act 2024
Same happening all over again
"Rationale. The stated reason for the order was that hard times had caused "hoarding" of gold, stalling economic growth and worsening the depression as the US was then using the gold standard for its currency."
Notes:
"Historical data from the launch of the first gold ETF in the US in November 2004 provides insights into a potential Bitcoin ETF's impact. Gold's price steadily increased from $375 in May to $442 on the ETF launch day, reaching $454 shortly after due to substantial inflows."
"inflows
a large amount of money, people, or water, that moves or is transferred into a place."
"$1.4B Inflows Into Spot Bitcoin ETF After First Two Trading Sessions"
January 3, 2024 filling s4-
"reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc."
"The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock."
Y'all CAN LOAD NOW